We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lombard Med.Tec | LSE:LMT | London | Ordinary Share | GB00B7FT8W85 | ORD 20P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 188.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
28/1/2010 12:33 | National Abdominal Aortic Aneurysm Screening Programme 28 January 2010 The Programme will set national standards and protocols for the delivery of local screening services and will co-ordinate the implementation of the programme across England. | greynag | |
25/1/2010 12:52 | -->nod, Only ~11% of the offer last Jan was taken up. It may be that you get all you want this time also. That's if you want any of course :-) | greynag | |
25/1/2010 08:10 | Has anybody bee able to work out what the scaling back is likely to be... as a minimum and as likely... | nod | |
22/1/2010 09:15 | it's hard to understand why a PI would sell at this low point and ahead of funding... but they are. | nod | |
21/1/2010 14:38 | Andrbea, I wonder if so. Is it not more likely that competitors (if any) are closing the gap while LMT takes so long to deliver approval for the markets?? | roundyg | |
21/1/2010 13:29 | will accept the open offer I decided... the technology must be getting better, year on year? :-) | andrbea | |
19/1/2010 20:55 | roundyg - yes, you are probably right, this is Last Chance Saloon gambling. With the extra funds the odds of success look better than even, whereas the current share price looks more like a 1 in 20 chance of survival. Last year LMT gained European approval and some of the cash raised is targeted at European sales. Europe is a big market. The rest of the cash goes to the US trials and approval. They also mention development of the next generation delivery system. "We believe the success of this fundraising will enable us to capture market share in Europe, complete the regulatory process in the important US market and ensure that we gain maximum returns for our shareholders." | nod | |
19/1/2010 17:49 | Nod / Webshares, I like your optimism but the only hope LMT has is to complete next set of trials, have FDA approval granted and hopefully have Boston / Medtroinic / Abbott come in and take over. This has to be last chance saloon. LMT previously had developed dynamic polymers with elution properties but failure to demonstrate its capabilities in time cost them... is has faded into oblivion. Same will hapen with AAA if not fastracked to approval. | roundyg | |
19/1/2010 11:08 | I've just subsribed to the share offer, and as you said nod hopefully after the refunding the share price will rise agai and hopefully get back even before the (hopeful) massive rise end of 2011 | webshares | |
19/1/2010 08:28 | I think I'll submit for more shares under the offer. Once LMT has the cash, I reckon we will see a re-run of early 2009 when the price went from 0.5p to 2.75p in four months. This time I want to be able to sell portions as the price moves up, say at 50% then 100%. I didn't have enough shares to do that in 2009. We may have to wait a little while this year for market sentiment to turn less bearish, but I'm sure we'll see 2.75p before the year is out. | nod | |
19/1/2010 02:16 | TD Waterhouse requires my decision on the offer by 25 January. Shares offered at 1p. | nod | |
15/1/2010 10:30 | A bit of price movement today. I've added 30k at 1.07 I will look to add again if price drops. | nod | |
14/1/2010 19:57 | Today saw the largest daily volume of the past 12 months. And they were all buys and all O trades. Bodes well. Like me, investors expecting a bounce now the cash situation is likely resolved again. Look at what happened to the share price last January after the fund raising. | nod | |
14/1/2010 15:21 | True, let's hope there's some return some day from this. | roundyg | |
14/1/2010 15:15 | roundyg...clearly Invesco feel there is a return here , appreciate they have lots of cash , but would they really invest that amount on a punt! | jotoha2 | |
14/1/2010 14:37 | Its tempting to load up on a few shares if available @ 1p if upward trend was likely. I'm in here a long time, already lost a small fortune, would be nice to claw back some of it. My fear, as andrbea says, this is a perennial re-financing operation, despite numerous changes in mgmt. Hard to have renewed faith. | roundyg | |
14/1/2010 14:04 | this company has to refunded annually (on life support!) we should be happy to be alive for another year. It's permanently priced to go bust, so this kind of news should propel it upwards IMO, dilution or no dilution. | andrbea | |
14/1/2010 13:59 | So in summary, we are looking at a dilution of greater than 1 in 2, correct, or have I misread? Why haven't we seen a move in SP? | roundyg | |
14/1/2010 09:37 | London, UK, 14 January 2010 - Lombard Medical Technologies PLC (AIM: LMT), the specialist medical device company announces that the circular relating to the Company's recent fundraising, announced on 13 January 2010, has been posted to shareholders. The circular is also available on the Company's website at: (44 pages) | nod | |
13/1/2010 23:08 | Deal of the day Lombard Medical Technologies was unchanged at 1.05p yesterday after the specialist medical device group raised £13 million in a share placing by Evolution Securities and Eden Financial. The money will be used to expand the group's European sales and marketing infrastructure and to try to get American approval for its Aorfix stent graft. | peterboroughmatt | |
13/1/2010 21:34 | nod , this will not be sold until they get FDA approval , its why all the long term holders have supported this all the way down from £1.59 , I remember mdy putting in around £1.2 million @24p , so they are all sitting on mega loses , fda gives them the get out of jail card. | jotoha2 | |
13/1/2010 20:42 | The main things I walk away with are: LMT will not have to look at raising cash for another 18 months or so Invesco will have looked at this business very ruthlessly and could easily have walked away - a loss would have been a drop in the ocean for them Invesco believes 1p to be good value - they could have gone for 0.7p This sets a floor for the share price at 1p - any fall below 1p should be short-term Invesco will be in full control of LMT and will be ruthless if any offers are forthcoming; they will see it purely as a financial transaction and not about their jobs | nod | |
13/1/2010 20:27 | A pretty good days work for Evolution and Eden too... 1.2 million expenses. | nod | |
13/1/2010 20:23 | There's a lot of information to digest from the RNS. Looks like a sale has been ruled out. Reading between the lines, I would guess they had an offer but it was too low. However, I'm sure Invesco will seriously consider any good offers this year. Invesco will be in complete control of LMT's destiny with 44.54%. They will come out of this very well but have been a long-term investor and subscribed to previous fundraisings. I assume the other major shareholders have approved this proposal... Major Shareholders Shares in issue: 841.3m 1p Ords Name Amount % Holding Invesco Perpetual 221,565,235 26.34 Perpetual Income & Growth Investment Trust PLC 171,682,376 20.41 (duplicate?) Craig Robert Rennie * 101,237,771 12.03 Devices ULC 100,000,000 11.89 Fidelity International Ltd 75,143,678 8.93 Octopus IHT AIM PLC 54,821,428 6.52 Status Partners Funds 35,905,520 4.27 Patrick Paul 34,163,268 4.06 Camden Partners(dup) 32,720,011 3.89 Richard Marvin Johnston * 32,720,011 3.89 Nomura Code 32,022,960 3.81 Other Directors Name Amount % Holding Martin Terry Rothman 3,611,115 0.429 Michael Anthony Stevens 1,710,035 0.203 Brian Howlett 1,522,277 0.181 Timothy Tim Cook 1,515,120 0.180 Simon John Neathercoat 1,430,891 0.170 Timothy Richard Hall 1,115,000 0.133 * = Director | nod |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions